- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Adverse risk, newly diagnosed, induction therapy
Total 58376 results
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
St. Jude Children's Research HospitalNot yet recruitingAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
Hematology department of the 920th hospitalRecruitingAcute Myeloid LeukemiaChina
-
Zhujiang HospitalRecruitingLeukemia, Myeloid, AcuteChina
-
Alice MimsNational Cancer Institute (NCI)Recruiting
-
Mehdi QiabiRecruitingEsophageal Cancer | Nutrition Aspect of CancerCanada
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia, AdultChina
-
Sunnybrook Health Sciences CentreLondon Regional Cancer Program, Canada; Toronto Sunnybrook Regional Cancer...RecruitingOtotoxic Hearing LossCanada
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Novartis PharmaceuticalsRecruitingFLT3-mutated Acute Myeloid LeukemiaKorea, Republic of, Germany, Italy, Turkey, Czechia, Jordan, Slovenia, Austria, Poland, Japan, Russian Federation, United States, Greece
-
Arog Pharmaceuticals, Inc.RecruitingNewly Diagnosed FLT3 Mutated AMLUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); University of Florida; The Pew Charitable TrustsActive, not recruitingBrain and Central Nervous System TumorsUnited States, Australia
-
Chen SuningCompletedB Acute Lymphoblastic LeukemiaChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEpendymoma | Anaplastic Ependymoma | Clear Cell Ependymoma | Brain Ependymoma | Cellular Ependymoma | Papillary EpendymomaUnited States, Canada, Australia, New Zealand
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | LeukemiaHong Kong, Canada, Belgium, France, Spain, Taiwan, United States, Australia, Czechia, Hungary, Italy, Israel, Japan, Korea, Republic of, Germany, China, Ukraine, Romania, Argentina, Croatia, Brazil, Serbia, Russian Federation, Portugal, Bulgari... and more
-
Institut de Recherches Internationales ServierCelgene CorporationActive, not recruitingUntreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS) | AML Arising From Antecedent Hematologic Disorder (AHD) | AML Arising After Exposure to Genotoxic InjuryUnited States, Germany, Netherlands
-
ChimerixCompletedAcute Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)United States, Spain, Belgium, Germany, Japan, Taiwan, Turkey, Italy, Australia, Austria, Switzerland, Israel, Bulgaria, France, Norway, Brazil, Poland, Portugal, Czechia, Argentina
-
BioSight Ltd.CompletedAcute Myeloid LeukemiaUnited States, Israel
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Incyte CorporationActive, not recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Hospital Universitario Dr. Jose E. GonzalezCompleted
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States, Singapore
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Switzerland
-
Cellectis S.A.WithdrawnAcute Myeloid Leukaemia
-
Umeå UniversityCompletedFluid Therapy | Hemodynamic Instability | Anesthesia; Adverse EffectSweden
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Dayanand Medical College and HospitalColitis & Crohn's Foundation (India)UnknownUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic MildIndia
-
Nanfang Hospital of Southern Medical UniversityGuangzhou First People's Hospital; Second Affiliated Hospital, Sun Yat-Sen... and other collaboratorsUnknownAcute Myeloid Leukemia | Minimal Residual Disease | Granulocyte Colony-stimulating FactorChina
-
Shanghai Changzheng HospitalCompleted
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
CelgeneWithdrawnNeoplasms | Hematologic Diseases | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Therapeutic Uses | Plasma Cells
-
University of UlmCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
University of UlmCompletedAcute Myeloid LeukemiaGermany, Austria
-
Merck Sharp & Dohme LLCAESCA Pharma GmbHTerminated
-
University of PittsburghTerminatedAcute Myeloid LeukemiaUnited States
-
Indiana UniversityIndiana University Melvin and Bren Simon Cancer CenterCompletedBrain and Central Nervous System Tumors | Drug/Agent Toxicity by Tissue/Organ | Bone Marrow SuppressionUnited States
-
Guangdong Provincial People's HospitalUnknown
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Puerto Rico, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed